Oncogene-tumor suppressor gene feedback interactions and their control.
Bethesda, United States. In Math Biosci Eng, Jan 2016
We propose the hypothesis that for a particular type of cancer there exists a key pair of oncogene (OCG) and tumor suppressor gene (TSG) that is normally involved in strong stabilizing negative feedback loops (nFBLs) of molecular interactions, and it is these interactions that are sufficiently perturbed during cancer development.
The Rise and Fall of Hyaluronan in Respiratory Diseases.
Cleveland, United States. In Int J Cell Biol, 2014
During inflammation in the airways, HA is often covalently modified with heavy chains from inter-alpha-inhibitor via the enzyme tumor-necrosis-factor-stimulated-gene-6 (TSG-6) and this modification promotes the interaction of leukocytes with HA matrices at sites of inflammation.
The Bone Morphogenetic Proteins and Their Antagonists.
London, United Kingdom. In Vitam Horm, 2014
One mechanism for enabling tight spatiotemporal control of their activities is through a number of antagonist proteins, including Noggin, Follistatin, Chordin, Twisted gastrulation (TSG), and the seven members of the Cerberus and Dan family.
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.
Houston, United States. In Nat Rev Cancer, 2011
Genes identified as being mutated in Wilms' tumour include TP53, a classic tumour suppressor gene (TSG); CTNNB1 (encoding β-catenin), a classic oncogene; WTX, which accumulating data indicate is a TSG; and WT1, which is inactivated in some Wilms' tumours, similar to a TSG.